NCT06000683Completed
Empowering Patients' Lung Cancer Screening Uptake
Empowering Patients' Lung Cancer Screening Uptake (Empower LCS)
Source: ClinicalTrials.gov · Last updated 20 Feb 2026
Brief summary (registry, in English)
Lung cancer is the leading cause of cancer related mortality. Lung cancer screening (LCS) with low dose computed tomography (LDCT) decreases mortality rate of lung cancer by 20%. Yet many patients who are eligible for lung cancer screening are still falling through the cracks which prevents patients the ability to detect lung cancer early. This study will test the effect of a a multi-level intervention on ordering LDCT within 6 months after patient enrollment. Our proposed intervention includes (1) Primary care provider notifications of patients' LCS eligibility; (2) patients' education ; (3) patients' referral to financial navigation resources; and (4) patients' reminder to discuss LCS during PCP visit.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 79 (actual)
- First submitted
- 14 Aug 2023
- Start date
- 13 Oct 2023
- Primary completion date
- 21 Mar 2025
- Lead sponsor
- University of California, Irvine
- Diseases
- Lung cancer
- NCT number
- NCT06000683
What you commit to
- Study type: Interventional
- Participants enrolled: 79
- From 13 Oct 2023 to the primary completion date, 21 Mar 2025
- 7 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- Patients' Inclusion Criteria:
- Aged 50- 80 years of age.
- Be able to Speak English, Spanish, or Vietnamese
- Must have a scheduled appointment with their Primary Care Providers within next one to three months.
- The Scheduled PCP appointment is at any of the UCI Health primary care clinics in Orange County including two UCI federally qualified health centers
- History of 20 pack year smoking history ( based on survey self report)
- Current smoker or a former smoker who has quit smoking within the last 15 years (based on survey self report)
- Patients' Exclusion Criteria:
- Prior history of lung cancer
- chest CT for any reason in the last 12 months based on self-report and UCI EMR
- history of Alzheimer's disease or dementia
- Providers' Inclusion Criteria:
- Primary Care Providers whose patients were enrolled in the Empower LCS trial.
- Received notifications about the eligibility of their patients for lung cancer screening.
Age in the registry: 50 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (7)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UCI Health - Costa Mesa Coordinator of this site? Confirm its status | Costa Mesa | United States | Unknown status |
| UCI Health Gottschalk Medical Plaza Coordinator of this site? Confirm its status | Irvine | United States | Unknown status |
| UCI Health - Laguna Hills Coordinator of this site? Confirm its status | Laguna Hills | United States | Unknown status |
| UCI Health - Newport Beach MacArthur Coordinator of this site? Confirm its status | Newport Beach | United States | Unknown status |
| UCI Medical Center Coordinator of this site? Confirm its status | Orange | United States | Unknown status |
| UCI Health - Tustin Coordinator of this site? Confirm its status | Tustin | United States | Unknown status |
| UCI Health - Yorba Linda Coordinator of this site? Confirm its status | Yorba Linda | United States | Unknown status |
Related publications
- Patients' and Providers' Perspective of a Multi-level Approach to Improve Participation in Low-dose CT for Lung Cancer Screening (Empower LCS): A Mixed-Methods Analysis.Acad Radiol · 2026 · PMID 41904093
- Reliability of Electronic Medical Record to Assess Patient's Eligibility for Lung Cancer Screening: Analysis of Two Pilot Trials.J Am Coll Radiol · 2025 · PMID 41338703
- A Multilevel Approach to Improve Participation in Low-Dose CT for Lung Cancer Screening (Empower LCS): A Single-Arm Pilot Feasibility Clinical Trial.J Am Coll Radiol · 2026 · PMID 41241060
This page is information, not medical advice. Discuss any trial with your doctor.